By Daniel M. Gerstein, RealClearDefense: “The strategy proclaims that managing the risk of biological threats is in the “vital interest” of the United States, whether such threats are naturally occurring diseases, accidents involving dangerous pathogens, or deliberate attacks using biological agents.”